110P Patient preferences for adjuvant endocrine treatment of high-risk HR+/HER2- breast cancer: An adaptive choice-based conjoint analysis study from Germany

Autor: Wöckel, A., Park-Simon, T-W., Korfel, A., Raab, K., Silberzahn, H., Tesch, H.
Zdroj: In ESMO Open May 2023 8(1) Supplement 4
Databáze: ScienceDirect